[News Brief] Lotus Pharma Commences South Korean Distribution of Uro-Vaxom
Lotus Pharmaceutical has announced that its subsidiary, Alvogen Korea, has commenced distribution of Uro-Vaxom in South Korea following an agreement…
Press Release
[News Brief] Bristol Myers Squibb Names Singapore as Pan Asia Hub
Bristol Myers Squibb (BMS) has recognised Singapore as its new Pan Asia Cluster (PAC) hub, supported by the Singapore Economic…
[News Brief] Argent Plastic Surgery Relocates to Mount Alvernia Hospital
Argent Plastic Surgery has relocated to a larger, purpose-built clinic at Mount Alvernia Hospital Medical Centre A in Singapore, marking…
[News Brief] REPROCELL Seeks Japan Approval for Stem Cell Therapy
REPROCELL has submitted an application for manufacturing and marketing approval in Japan for Stemchymal, a regenerative medicine product intended to…
[News Brief] UCL and Eisai Extend Neurodegenerative Disease Research Partnership
University College London (UCL) and Eisai Co., Ltd. have signed a new agreement extending their collaboration in drug discovery and…
[News Brief] Sanyou Bio and Baiyunshan Xihe Partner on Radiopharmaceutical Development
Sanyou Biopharmaceutical and Guangzhou Baiyunshan Xihe Health Pharmaceutical have signed a strategic collaboration agreement to co-develop radiopharmaceutical and radiodiagnostic products…
[News Brief] Cadila Pharmaceuticals and Wellesta Holdings Sign Joint Venture MoU
Cadila Pharmaceuticals and Wellesta Holdings have signed a memorandum of understanding to establish a strategic joint venture focused on commercialising…
[News Brief] Mahidol University Partners with WE-WIN on Pharmaceutical Research
Mahidol University’s Faculty of Pharmacy and Taiwan’s WE-WIN Bio-Medical Co., Ltd. have signed a memorandum of understanding to strengthen collaboration…
[News Brief] CPHI South East Asia 2026 to Showcase Regional Pharma Partnerships
CPHI South East Asia 2026 will take place from 8 to 10 July 2026 at the Queen Sirikit National Convention…
[News Brief] China NMPA Standardises Medical Device Reclassification Procedures
China’s National Medical Products Administration (NMPA) has issued Announcement No. 52/2026, establishing a procedural framework to standardise the management of…